您要查找的是不是：
- Objective:To observe the effect of Salmeterol Xinafoate and Fluticasone Propionate Powder for inhalation(Seretide) on lung function of asthmatic children. 目的:观察哮喘患儿经吸入沙美特罗替卡松(舒利迭)后对肺功能的影响程度。
- AIM: To evaluate the clinical efficacy and safety of salmeterol xinafoate and fluticasone propionate in the treatment of moderate and severe asthma children. 方法:将80例中、重度哮喘病儿分成沙美特罗替卡松粉吸入剂治疗组(治疗组)和氟替卡松治疗组(对照组)。
- Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation 沙美特罗氟替卡松粉吸入剂
- Keywords Salmeterol Xinafoate;fluticasone propionate;children;lung function;asthma; 沙美特罗;氟替卡松;儿童;肺功能;哮喘;
- Keywords salmeterol xinafoate;residual organic solvent;capillary gas chromatography;determination; 羟萘甲酸沙美特罗;有机溶剂残留量;气相色谱法;测定;
- salmeterol xinafoate 沙美特罗昔萘酸酯<支气管扩张药>
- Aim To develop a new synthetic route to salmeterol. 目的研究开发平喘药沙美特罗的新合成路线。
- Conclusion Combined therapy with salmeterol and fluticasone produces better results than simple one with fluticasone. 结论舒利迭治疗儿童哮喘的临床疗效较好。
- Results:Salmeterol and fluticasone propionate powder marked improvement in asthma symptoms. 结果:沙美特罗替卡松粉剂明显改善哮喘病状。
- Identified trials meeting criteria included 26 trials comparing salmeterol vs placebo and 8 trials comparing salmeterol vs salbutamol. 符合纳入标准的包括研究沙美特罗对比安慰剂26个临床试验和研究沙美特罗对比沙丁胺醇的8个临床试验。
- For every 188 people treated with regular salmeterol, 1 extra serious adverse event occurred at 28 weeks (95% CI, 95 - 2606). 规律使用沙美特罗的188名患者中，在28周时有一例额外的严重不良事件的发生(95%25 CI, 95 - 2606)。
- Conclusion: Bronchodilation with salmeterol reduced dyspnea during walking and improved walking capacity in patients with COPD. 结论：沙美特罗等支气管扩张剂能够改善COPD患者呼吸困难和和行走能力。
- Objective:To observ salmeterol and fluticasone propionate inhalation powder on the treatment of bronchial asthma,and security. 目的:观察沙美特罗替卡松粉剂吸入后对支气管哮喘的治疗效果、安全性。
- Conclusion Combined Salmeterol and fluticasone propionate in the diskus device inhalation could obviously improve the lung function in the children with moderate or severe asthma. 结论吸入舒利迭可以显著改善中重度支气管哮喘儿童的肺功能。
- Clinical implications of this review are that for patients with asthma that is poorly controlled with moderate doses of inhaled corticosteroids, additional salmeterol can give symptomatic benefit. 该综述与临床的联系在于：对于使用中等剂量吸入激素控制效果欠佳的哮喘患者，加用沙美特罗有助于症状的改善。
- Compared with regular salbutamol, regular salmeterol was not associated with a significant increase in fatal or nonfatal serious adverse events in patients not taking inhaled corticosteroids. 对不吸入糖皮质激素的患者来说，规律使用沙美特罗与规律使用沙丁胺醇相比，其致死性及非致死性严重不良事件的发生率并无显著增加。
- Salmeterol flutieasone propionate 舒利迭
- salmeterol (SM) and fluticasone propionate (FP) 沙美特罗／丙酸氟替卡松
- salmeterol and fluticasone propionate inhalant 沙美特罗替卡松干粉
- Keywords formoterol turbubaler;salmeterol;bronchial asthma; 福莫特罗都保;沙美特罗;支气管哮喘;
